Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company?s products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||0.15||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||16.09%||Sales Growth - Q/Q||1.81%||P/E||110.8|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-2.46%||ROE||-3.49%||ROI||-3.08%|
|Current Ratio||2.81||Quick Ratio||1.63||Long Term Debt/Equity||0.27||Debt Ratio||0.26|
|Gross Margin||23.49%||Operating Margin||-10.51%||Net Profit Margin||-4.4%||Dividend Payout Ratio|
|Cash From Financing Activities||4.45 M||Cash From Investing Activities||-5.04 M||Cash From Operating Activities||1.34 M||Gross Profit||13.28 M|
|Net Profit||-670 K||Operating Profit||-7.26 M||Total Assets||396.5 M||Total Current Assets||202.6 M|
|Total Current Liabilities||72.09 M||Total Debt||48.42 M||Total Liabilities||117.22 M||Total Revenue||56.89 M|
|High 52 week||25.28||Low 52 week||17.72||Last close||20.46||Last change||1.49%|
|RSI||50.88||Average true range||0.53||Beta||0.93||Volume||248.19 K|
|Simple moving average 20 days||1.87%||Simple moving average 50 days||-2.39%||Simple moving average 200 days||-3.81%|
|Performance Week||3.59%||Performance Month||-6.19%||Performance Quart||2.15%||Performance Half||-0.58%|
|Performance Year||13.29%||Performance Year-to-date||2.81%||Volatility daily||1.32%||Volatility weekly||2.94%|
|Volatility monthly||6.04%||Volatility yearly||20.91%||Relative Volume||233.02%||Average Volume||216.07 K|
|New High||New Low|
2020-06-02 16:05:10 | Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
2020-05-09 08:21:51 | Is Now The Time To Put Amphastar Pharmaceuticals NASDAQ:AMPH On Your Watchlist?
2020-05-09 01:42:48 | Edited Transcript of AMPH earnings conference call or presentation 7-May-20 9:00pm GMT
2020-05-08 16:31:00 | Amphastar Pharmaceuticals Inc AMPH Q1 2020 Earnings Call Transcript
2020-05-06 12:10:04 | Why the Earnings Surprise Streak Could Continue for Amphastar AMPH
2020-04-13 17:16:16 | Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
2020-03-29 08:36:13 | Is Amphastar Pharmaceuticals, Inc.'s NASDAQ:AMPH CEO Pay Justified?
2020-03-28 14:46:01 | Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
2020-03-24 09:47:01 | What Bargain Hunting? Tap 5 Stocks With Rising P/E
2020-03-20 10:44:02 | Generic Drugs Industry's Prospects Uncertain Amid Coronavirus
2020-03-12 18:05:10 | Amphastar Pharmaceuticals AMPH Q4 Earnings and Revenues Beat Estimates
2020-03-12 15:00:00 | Amphastar Pharmaceuticals, Inc. to Host Earnings Call
2020-02-13 05:48:11 | Amphastar Pharmaceuticals NASDAQ:AMPH Could Easily Take On More Debt
2019-12-17 19:19:36 | Here is What Hedge Funds Think About Amphastar Pharmaceuticals Inc AMPH
2019-12-02 05:16:24 | Based On Its ROE, Is Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH A High Quality Stock?
2019-11-15 06:00:00 | Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
2019-11-08 17:14:29 | Edited Transcript of AMPH earnings conference call or presentation 7-Nov-19 10:00pm GMT
2019-10-28 14:14:46 | Is Amphastar Pharmaceuticals Inc AMPH A Good Stock To Buy?
2019-10-21 06:17:56 | How Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH Can Impact Your Portfolio Volatility
2019-09-21 07:58:08 | How Much Did Amphastar Pharmaceuticals, Inc.'s NASDAQ:AMPH CEO Pocket Last Year?
2019-08-29 06:01:00 | Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference
2019-08-22 08:44:31 | Does Amphastar Pharmaceuticals NASDAQ:AMPH Have A Healthy Balance Sheet?
2019-08-08 11:59:39 | Edited Transcript of AMPH earnings conference call or presentation 7-Aug-19 9:00pm GMT
2019-08-07 23:24:11 | Amphastar Pharmaceuticals Inc AMPH Q2 2019 Earnings Call Transcript
2019-08-07 20:55:12 | Amphastar Pharmaceuticals AMPH Q2 Earnings and Revenues Beat Estimates
2019-07-23 13:19:54 | Should You Be Holding Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH?
2019-06-29 18:18:02 | Is Amphastar Pharmaceuticals Inc AMPH A Good Stock To Buy ?
2019-05-31 06:00:00 | Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference